Clinical Trials Sponsored by Biosynex Company

Total 6040 results

University Hospital, Clermont-Ferrand
Biosynex Company

Recruiting

Preterm Premature Rupture of Fetal Membranes: Cervical Ultrasound and Biological Markers to Diagnose Prematurity (RECHOBIOL) (RECHOBIOL)

Premature Rupture of Membrane

France
University Hospital, Clermont-Ferrand
Mr. Thierry PAPER - Biosynex Company

Unknown

Diagnostic Tests in the Context of Threatened Preterm Labour (PREMAQUICK)

Biomarkers | Predictive Value of Tests | Preterm Labor | Preterm Delivery | Immunochromatographic Assay

France
Biosynexus Incorporated

Completed

Safety and Pharmacokinetics Study in Adults for the Prevention of S. Epidermidis Infection in Low Birth Weight Infants

Staphylococcal Sepsis

United States
Biosynexus Incorporated

Completed

Safety and Efficacy of Pagibaximab Injection in Very Low Birth Weight Neonates for Prevention of Staphylococcal Sepsis

Staphylococcal Sepsis

United States
Biosynexus Incorporated
GlaxoSmithKline

Completed

Safety and Pharmacokinetics Study in VLBW Neonates With BSYX-A110 (N002)

Neonatal Staphylococcal Sepsis

United States
BioSyngen Pte Ltd

Unknown

A Study of Syngenon (BSG-001) for Inhalation in Subjects With Malignant Pleural Effusion and/or Malignant Ascites

Malignant Ascites | Malignant Pleural Effusion

Australia
Biosynexus Incorporated
GlaxoSmithKline

Completed

Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity Study in VLBW Neonates of BSYX-A110 (N003)

Staphylococcal Sepsis

United States
BioSyngen Pte Ltd

Not yet recruiting

A Phase 1 Study of BRG01 in Subjects With Relapsed/Metastatic Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma

EBV-positive Nasopharyngeal Carcinoma

China
University Hospital Freiburg
Biosyn

Completed

Comparison of Selenium Levels in HCV- Infected Patients at Different Stages of Disease

Liver Cirrhosis | Carcinoma, Hepatocellular | Hepatitis C

Germany
BioSyngen Pte Ltd
Shenzhen Second People's Hospital

Not yet recruiting

Investigator-initiated Phase I Exploratory Clinical Study of the Safety, Tolerability, and Efficacy of BST02 Injection in the Treatment of Locally Advanced/Metastatic Liver Cancer

Locally Advanced/Metastatic Liver Cancer

China
Kompetenznetz Sepsis
Biosyn; Brahms AG

Completed

Placebo Controlled Trial of Sodium Selenite and Procalcitonin Guided Antimicrobial Therapy in Severe Sepsis (SISPCT)

Septic Shock | Severe Sepsis

Germany
BioSync Scientific Pvt. Ltd.
Cardialysis BV; MIV Therapeutics Inc.

Unknown

Hydroxyapatite Active Pro Healing Clinical Trial Program (HApFIM)

Coronary Artery Disease
BioSyngen Pte Ltd
The First Affiliated Hospital of Zhengzhou University

Recruiting

BGT007H Cells for the Treatment of Recurrent/Refractory Gastrointestinal Tumors

Gastrointestinal Tumors

China
RWTH Aachen University
biosyn Arzneimittel GmbH; Cardiodevice Stiftung

Completed

High-dose Selenium Supplementation in Patients With Left Ventricular Assist (SOS-LVAD)

Ventricular Dysfunction, Left

Germany
Perrigo Company

Completed

Bioequivalence Study Between Two Oral Formulations of Famotidine Tablets Under Fasting Conditions

Bioavailability
Perrigo Company

Completed

Bioequivalence Study Between Two Oral Formulations of Naproxen 500 mg Tablets Under Fasting Conditions

Bioequivalency
Perrigo Company

Completed

Bioequivalence Study Between Two Oral Formulations of Famotidine Tablets Under Fed Conditions

Bioavailability
Genome & Company

Not yet recruiting

A First-in-human Study of GENA-104A16 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

Korea, Republic of
OBMedical Company

Completed

Electrode-Based Sensor for Non-Invasive Fetal Heart Rate Monitoring With Improved Reliability (FHR)

Laboring Women With Ultrasound and FSE Monitoring

United States
Perrigo Company

Completed

Bioequivalence Study Between Two Oral Formulations of Ibuprofen 800 mg Tablets Under Fasting Conditions

Bioequivalency
Perrigo Company

Completed

Bioequivalence Study Between Two Oral Formulations of Ibuprofen 800 mg Tablets Under Fed Conditions

Bioequivalency
Perrigo Company

Completed

Bioequivalence Study Between Two Oral Formulations of Naproxen 500 mg Tablets Under Fed Conditions

Bioequivalency
Biosyn
United States Agency for International Development (USAID); FHI 360

Unknown

Trial of SAVVY Vaginal Gel and HIV in Nigeria

HIV Infections

Nigeria
Biosyn
National Institute of Allergy and Infectious Diseases (NIAID)

Unknown

Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Enhanced MRI Techniques to Increase Resolution

HIV

United States
Biosyn
National Institute of Allergy and Infectious Diseases (NIAID)

Unknown

An Imaging Trial of the Distribution of Topical Gel Formulations in the Human Vagina

HIV Infections

United States
DynPort Vaccine Company LLC, A GDIT Company

Completed

A New Anthrax Vaccine Administered by the Intramuscular (IM) Route in Healthy Adults

Anthrax

United States
Biosyn
National Institute of Allergy and Infectious Diseases (NIAID)

Unknown

An Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Assessment of Bare Spots

HIV Infections

United States
DynPort Vaccine Company LLC, A GDIT Company

Withdrawn

Safety, Tolerability and Immunogenicity of the Venezuelan Equine Encephalitis (VEE) Attenuated Live-Virus Vaccine

Venezuelan Equine Encephalitis

United States
DynPort Vaccine Company LLC, A GDIT Company

Completed

Study to Evaluate the Safety, Tolerability and Immunogenicity of Recombinant Botulinum Vaccine A/B in Healthy Adults

RECOMBINANT BOTULINUM VACCINE A/B

United States
DynPort Vaccine Company LLC, A GDIT Company

Completed

Double Blind, Safety and Immunogenicity Study of Recombinant Botulinum Vaccine A/B

Botulism Vaccine

United States
DynPort Vaccine Company LLC, A GDIT Company

Completed

Randomized Single-Blinded Study to Evaluate Safety and Immunogenicity of Recombinant Plague Vaccine With and Without Adjuvant

Plague Vaccine

United States
DynPort Vaccine Company LLC, A GDIT Company

Withdrawn

Phase 3, Randomized, Safety, Lot Consistency and Clinical Benefit Study of Recombinant Botulinum Vaccine A/B (rBV A/B)

Botulism
DynPort Vaccine Company LLC, A GDIT Company

Completed

Title: Recombinant Plague Vaccine rF1V in Healthy Volunteers

Healthy Volunteers

United States
DynPort Vaccine Company LLC, A GDIT Company

Completed

Safety, Tolerability & Immunogenicity of the Recombinant Plague Vaccine rF1V

Pneumonic Plague | Preventive Therapy

United States
DynPort Vaccine Company LLC, A GDIT Company

Completed

Study of Reactogenicity, Safety, Immunogenicity, and Pock Lesion Formation of a Cell-Cultured Smallpox Vaccine Compared to Dryvax®

Smallpox

United States
RAI Services Company

Not yet recruiting

CSD231005 Nicotine Pouch Biomarkers of Exposure

Smoking | Tobacco Use

United States
Balmoral Medical company

Not yet recruiting

A Study to Evaluate the Safety and Effectiveness Transdermal Compress Device in Participants With Transfemoral Amputations

Prosthesis and Implants
RAI Services Company

Recruiting

CSD200902: Assessment of Indoor Air Quality for a Heated Tobacco Product With Four Non-Combusted Cigarette Variants in an Environmental Testing Chamber

Smoking | Tobacco Use | Tobacco Smoking

United States
Kowa Company, Ltd.

Recruiting

A Phase 3 Study to Evaluate the Efficacy and Safety of K-877 in Chinese Patients With High TG and Low HDL-C

Hyperlipidemia

China
BrainScope Company, Inc.

Recruiting

Follow-up of mTBI Patients Discharged From the ED Using Standard Clinical Triage Including BrainScope One (MEDO)

TBI (Traumatic Brain Injury) | Concussion, Brain | MTBI - Mild Traumatic Brain Injury | Closed Head Injury

United States
The Medicines Company

Completed

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of a New Formulation of Oritavancin in Healthy Volunteers

Healthy

United States
Kowa Company, Ltd.

Completed

K-924 Phase III Confirmatory Study

Hypercholesterolemia

Japan
RAI Services Company

Completed

BRP1602: Evaluation of Technical and Logistical Feasibility to Measure Lung Permeability

Smoking | Tobacco Use | Smoking, Tobacco

United States
Kowa Company, Ltd.

Active, not recruiting

A Phase III Confirmatory Study of K-237

Covid19

Japan, Thailand
RAI Services Company

Completed

CSD201301: Study to Assess Elements of Abuse Liability for Four P13 Nicotine Pouches

Smoking | Tobacco Use | Tobacco Smoking

United States
RAI Services Company

Completed

CSD201201: Study to Assess Elements of Abuse Liability for Electronic Nicotine Delivery System P12

Smoking | Tobacco Use | Tobacco Smoking | Smoking Behaviors

United States
RAI Services Company

Completed

CSD201004: An Actual Use Study of P10 and P13 Nicotine Pouches Among U.S. Adult Smokers

Smoking | Tobacco Use | Tobacco Smoking

United States
RAI Services Company

Completed

CSD200907: A Study to Assess Elements of Abuse Liability for a Heated Tobacco Product With Four Non-Combusted Cigarette Variants

Smoking | Tobacco Use | Tobacco Smoking | Smoking Behaviors

United States
RAI Services Company

Completed

CSD1601: A Study to Evaluate the Exposure to Tar and Nicotine From Two Cigarette Products That Contain a Menthol Capsule in the Filter

Smoking | Tobacco Use | Tobacco Smoking

United States
RAI Services Company

Completed

CSD210904: Study to Assess Actual Use of a Heated Tobacco Product With Four Non-Combusted Cigarette Variants in Current Adult Smokers

Smoking | Tobacco Use | Tobacco Smoking

United States

3

Subscribe